Inmaculada Saguer-Martinez
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study.
Journal: Clinical and translational allergy
Published: January 28, 2026
Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.
Journal: International archives of allergy and immunology
Published: January 12, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
Journal: The World Allergy Organization journal
Published: December 22, 2025
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care.
Journal: Allergologie select
Published: October 10, 2025
Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: October 02, 2025
Authors' response.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: September 25, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S.
Journal: Clinical and translational allergy
Published: July 31, 2025
Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor: A Review.
Journal: Clinical and translational allergy
Published: June 02, 2025
Last Updated: 09/26/2026